A Multicenter Partially-Masked Randomized Controlled Study of Maximal Medical Therapy vs. Maximal Medical Therapy plus Optic Nerve Sheath Fenestration vs. Initial Medical Therapy plus Stereotactic Ventriculoperitoneal Cerebrospinal Fluid Shunting in Su

Brief description of study

When vision loss from IIH is moderate to severe, several medications and surgical treatments can be used. Although each of these treatments can be effective, doctors are still not sure which treatments work best. The purpose of this study is to find out which treatment works best to reduce or reverse visual loss in people with Idiopathic Intracranial Hypertension (IIH). The purpose of this study is to find out how different treatments work to reduce or reverse visual loss in people who have a condition where the pressure inside the skull increases for no known reason. This is called idiopathic intracranial hypertension (IIH). When vision loss from IIH is moderate to severe, several medications and surgical treatments can be used. Although each of these treatments can be effective, doctors are still not sure which treatments work best. This study aims to find out which treatment works best to restore vision for people with IIH.


Clinical Study Identifier: s18-00336
ClinicalTrials.gov Identifier: NCT03501966
Principal Investigator: Cinthi Pillai
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.